These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 11176912)

  • 21. Antivirals for influenza in healthy adults: systematic review.
    Jefferson T; Demicheli V; Rivetti D; Jones M; Di Pietrantonj C; Rivetti A
    Lancet; 2006 Jan; 367(9507):303-13. PubMed ID: 16443037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial.
    LaForce C; Man CY; Henderson FW; McElhaney JE; Hampel FC; Bettis R; Kudule L; Harris J; Yates P; Tisdale M; Webster A
    Clin Ther; 2007 Aug; 29(8):1579-90; discussion 1577-8. PubMed ID: 17919541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis.
    Jefferson T; Jones M; Doshi P; Del Mar C
    BMJ; 2009 Dec; 339():b5106. PubMed ID: 19995812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial.
    Monto AS; Robinson DP; Herlocher ML; Hinson JM; Elliott MJ; Crisp A
    JAMA; 1999 Jul; 282(1):31-5. PubMed ID: 10404908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials.
    Cooper NJ; Sutton AJ; Abrams KR; Wailoo A; Turner D; Nicholson KG
    BMJ; 2003 Jun; 326(7401):1235. PubMed ID: 12791735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of post-exposure prophylaxis with oseltamivir for those in contacts with influenza patients in pediatric wards].
    Shinjoh M; Sato S; Sugaya N; Mitamura K; Takeuchi Y; Kosaki K; Takahashi T
    Kansenshogaku Zasshi; 2004 Mar; 78(3):262-9. PubMed ID: 15103909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuraminidase inhibitors in pediatric patients: potential place in influenza therapy.
    Noyola DE
    Paediatr Drugs; 2003; 5(2):125-31. PubMed ID: 12529164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review of the use of neuraminidase inhibitors for prophylaxis of influenza.
    Kirkbride HA; Watson J
    Commun Dis Public Health; 2003 Jun; 6(2):123-7. PubMed ID: 12889291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical efficacy and safety of the selective oral neuraminidase inhibitor oseltamivir in treating acute influenza--placebo-controlled double-blind multicenter phase III trial].
    Kashiwagi S; Kudoh S; Watanabe A; Yoshimura I
    Kansenshogaku Zasshi; 2000 Dec; 74(12):1044-61. PubMed ID: 11193557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oseltamivir.
    Bardsley-Elliot A; Noble S
    Drugs; 1999 Nov; 58(5):851-60; discussion 861-2. PubMed ID: 10595865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral oseltamivir in human experimental influenza B infection.
    Hayden FG; Jennings L; Robson R; Schiff G; Jackson H; Rana B; McClelland G; Ipe D; Roberts N; Ward P
    Antivir Ther; 2000 Sep; 5(3):205-13. PubMed ID: 11075941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early therapy with the neuraminidase inhibitor oseltamivir maximizes its efficacy in influenza treatment.
    Gillissen A; Höffken G
    Med Microbiol Immunol; 2002 Dec; 191(3-4):165-8. PubMed ID: 12458353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative Effectiveness of Baloxavir Marboxil and Oseltamivir Treatment in Reducing Household Transmission of Influenza: A Post Hoc Analysis of the BLOCKSTONE Trial.
    Ikematsu H; Baba T; Saito MM; Kinoshita M; Miyazawa S; Hata A; Nakano S; Kitanishi Y; Hayden FG
    Influenza Other Respir Viruses; 2024 May; 18(5):e13302. PubMed ID: 38706384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Baloxavir Marboxil for Prophylaxis against Influenza in Household Contacts.
    Ikematsu H; Hayden FG; Kawaguchi K; Kinoshita M; de Jong MD; Lee N; Takashima S; Noshi T; Tsuchiya K; Uehara T
    N Engl J Med; 2020 Jul; 383(4):309-320. PubMed ID: 32640124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuraminidase inhibitors for treatment of influenza A and B infections.
    MMWR Recomm Rep; 1999 Dec; 48(RR-14):1-9. PubMed ID: 10632443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experience with oseltamivir in the control of nursing home influenza A outbreak.
    Shijubo N; Yamada G; Takahashi M; Tokunoh T; Suzuki T; Abe S
    Intern Med; 2002 May; 41(5):366-70. PubMed ID: 12058885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuraminidase inhibitors in the management of influenza--experience of an outpatient practice.
    Vogel GE
    Med Microbiol Immunol; 2002 Dec; 191(3-4):161-3. PubMed ID: 12458352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza.
    Hayden FG; Treanor JJ; Betts RF; Lobo M; Esinhart JD; Hussey EK
    JAMA; 1996 Jan 24-31; 275(4):295-9. PubMed ID: 8544269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effectiveness of oseltamivir on influenza and influencing factors: age of patients, type of influenza virus and timing of initial administration].
    Kawai N; Iwaki N; Kawashima T; Satoh I; Tsuchimoto T; Shigematsu T; Kondoh K; Maeda T; Hirotsu N; Kunishima O; Kashiwagi S
    Kansenshogaku Zasshi; 2003 Jun; 77(6):423-9. PubMed ID: 12872691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.